KEY-T 0.18 BIP.UN-T -0.15 POW-T -0.1 BBD.B-T 1.53 UNH-N -5.61 NTR-T 0.52 TGT-N 1.27
Syneron Medical Ltd. (ELOS-Q)
The ultimate 360° Tracker Your financial life in one place, automatically

Syneron Medical Ltd. (ELOS-Q)

NEW AI Investor Insights
0 watching

0.00
0.00 (0.00%) 1d
0

Related posts

Nervous markets await Nvidia
WATCH

Syneron Medical Ltd.(ELOS-Q)

Jul 07, 2006
Have about $6 of cash per share. Earnings should be $1.60. Missed 2 quarters in a row and the stock took a hit. Some key people have left. Has created doubt, but the trend in the industry is very good. He sold his holdings. Would buy if they start growing again.
Jean-Francois TardifJean-Francois Tardif
No
Unlock Rating
$20.550

Stock price when the opinion was issued

biotechnology pharmaceutical
PAST TOP PICK

Syneron Medical Ltd.(ELOS-Q)

Jun 05, 2006
(A Top Pick Feb 15/06. Down 27%.) Disappointed two quarters in a row. Forward expectations by US analysts have dropped. Have sold some shares. The industry is doing well. He'll wait for one more quarter.
Jean-Francois TardifJean-Francois Tardif
Owned
Unlock Rating
$19.400

Stock price when the opinion was issued

biotechnology pharmaceutical
WATCH

Syneron Medical Ltd.(ELOS-Q)

May 01, 2006
Still likes it, but there are some worrisome things. Have lost some top level management. The earnings are growing, have a great balance sheet and lots of cash. Waiting to see what the next quarter brings. Trading around 10 X earnings which is not expensive.
Jean-Francois TardifJean-Francois Tardif
Owned
Unlock Rating
$26.160

Stock price when the opinion was issued

biotechnology pharmaceutical
PAST TOP PICK

Syneron Medical Ltd.(ELOS-Q)

Apr 19, 2006
(A Top Pick Feb 15/06. Up 6%.) The beauty treatment sector is doing very well. Still likes.
Jean-Francois TardifJean-Francois Tardif
Owned
Unlock Rating
$29.400

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Syneron Medical Ltd.(ELOS-Q)

Feb 15, 2006
Recently, the stock was hit pretty hard because of lower than expected earnings forecast. Thinks they will make $2/2.20 a share in ’06. They have $5 in cash per share. Not very expensive.
Jean-Francois TardifJean-Francois Tardif
Owned
Unlock Rating
$27.830

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Syneron Medical Ltd.(ELOS-Q)

Jun 21, 2005
Sells machines to health care clinics. Just got approval from the FDA for a cellulite product. Expects great demand. Earnings have been rising very rapidly. Low multiples.
Jean-Francois TardifJean-Francois Tardif
Owned
Unlock Rating
$32.060

Stock price when the opinion was issued

biotechnology pharmaceutical
PAST TOP PICK

Syneron Medical Ltd.(ELOS-Q)

Jun 01, 2005
(A Top Pick Feb3/05. Up 20%.) Still likes. Trying to get approval on a new product. Analysts forcast for next year is $1.60 but he believes it could be as high as $2.50/3.00.
Jean-Francois TardifJean-Francois Tardif
Owned
Unlock Rating
$34.860

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Syneron Medical Ltd.(ELOS-Q)

Feb 03, 2005
Health and cosmetic industry is growing very strong. Company is very innovative. In '04, their earnings grew about 100%. Have $3 cash per share. Will be launching a new product for sunlight. Trades at 25 X current earnings.
Jean-Francois TardifJean-Francois Tardif
Owned
Unlock Rating
$29.000

Stock price when the opinion was issued

biotechnology pharmaceutical
Showing 1 to 8 of 8 entries
  • «
  • ‹
  • 1
  • ›
  • »

Syneron Medical Ltd.(ELOS-Q) Rating

Ranking : 1 out of 5

Star iconStar empty iconStar empty iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Syneron Medical Ltd. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Syneron Medical Ltd.(ELOS-Q) Frequently Asked Questions

What is Syneron Medical Ltd. stock symbol?

Syneron Medical Ltd. is a OTC stock, trading under the symbol ELOS-Q on the (). It is usually referred to as or ELOS-Q

Is Syneron Medical Ltd. a buy or a sell?

In the last year, there was no coverage of Syneron Medical Ltd. published on Stockchase.

Is Syneron Medical Ltd. a good investment or a top pick?

Syneron Medical Ltd. was recommended as a Top Pick by on . Read the latest stock experts ratings for Syneron Medical Ltd..

Why is Syneron Medical Ltd. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Syneron Medical Ltd. worth watching?

In the last year 0 stock analysts on Stockchase covered Syneron Medical Ltd.. The stock is worth watching.

What is Syneron Medical Ltd. stock price?

On , Syneron Medical Ltd. (ELOS-Q) stock closed at a price of $.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Latest Buy Signals

CLS-T -3.91$123.45
NVDA-Q 4.58$111.01
PEP-Q -1.93$133.38
IBM-N 3.08$232.41
RMD-N -0.22$235.88

Today's Top Picks

KEY-T 0.18$42.62
BIP.UN… -0.15$39.97
POW-T -0.1$50.8
BBD.B-… 1.53$91.21
UNH-N -5.61$418.64

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

ARE-T -0.27$15.4
CVX-N -0.34$138.73
XOM-N -0.06$108.57
CNQ-T -0.01$40.68
TD-T -0.03$86.17

Most Recent Experts

Greg Newman

Scotia Wealth Management

Stockchase Insights

5i Research

Jim Cramer - Mad Money

CNBC

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

© Stockchase Inc.